Blog

Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group

Breast International Group/X

Dec 13, 2024, 15:19

Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group

Breast International Group shared a post on X:

“SABCS24.

P3-11-03 poster on results of phase 2 DECRESCENDO study:

Neoadjuvant treatment with an anthracycline-free regimen in patients with HER2-positive, HR-negative, node-negative early breast cancer resulted in a high rate of pCR.”

For more updates, follow OncoDaily.

Anthracycline anthracycline-free Breast Cancer Breast International Group cancer DECRESCENDO study EU4Health HaDEA Jules Bordet Institute neoadjuvant treatment OncoDaily Oncology SABCS24

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

"The Doctor Who Always Has Candies in His Pocket": A Conversation with Professor Guangchao Zhang, Pioneer of Pediatric Surgical Oncology in China

Wanda Sykes and Breast Cancer: How She Went Against, How She Survived, and More

Special Coverage